Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Current Pharmaceutical Design|December 8, 2004
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agentsBrian D Green, Victor A Gault, Finbarr P M O'harte, et al.
Neuroscience|January 30, 2026
Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's diseasePaul Denver, Aisling Duffy, Rebecca T Kennedy, et al.
Bioscience Reports|August 9, 2021
A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed miceRachele A Perry, Sarah L Craig, Victor A Gault, et al.
Biochemical Pharmacology|May 8, 2012
Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25Christine M A Martin, Victor A Gault, Stephen McClean, et al.
Biological Chemistry|August 20, 2017
Locally produced xenin and the neurotensinergic system in pancreatic islet function and β-cell survivalDawood Khan, Srividya Vasu, R Charlotte Moffett, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 12, 2015
Isolation and characterisation of insulin-releasing compounds from Crotalus adamanteus, Crotalus vegrandis and Bitis nasicornis venomSara W M Moore, Vikas K Bhat, Peter R Flatt, et al.
Frontiers in Endocrinology|June 7, 2021
Proglucagon-Derived Peptides as TherapeuticsRyan A Lafferty, Finbarr P M O'Harte, Nigel Irwin, et al.
Pageof 10